Vaginal misoprostol and intravenous oxytocin for success of termination in the second-trimester intrauterine fetal demise: A randomized controlled clinical trial.

Nasrin Asadi Homeira Vafaei Kamaran HessamiMohammad Hasan DarabiMaryam Kasraeian Azam FarajiAzin AlaviNazanin AbdiAtena GissueiShohreh Roozmeh Khadijeh BazrafshanFereshteh Gharibpour

Published in: The journal of obstetrics and gynaecology research (2022)

Vaginal misoprostol was associated with higher termination rate than oxytocin without adverse events when used as the first-line treatment. Both methods yielded the same success rate when used as the second-line treatment.

Keyphrases

high dose
preterm birth
gestational age
low dose
combination therapy
smoking cessation